Flightpath
3 known investors
Flightpath Biosciences develops Targeted Bacterial Deletion, a platform that selectively removes harmful gram-negative bacteria while sparing the surrounding microbiome to interrupt infection-driven disease. Its pipeline targets bacterial drivers across oral and gastrointestinal diseases, infection-associated cancers, and women's health conditions.
BiotechDeep TechHealthtech
Investors · 3
Frequently asked questions
- What does Flightpath do?
- Flightpath Biosciences develops Targeted Bacterial Deletion, a platform that selectively removes harmful gram-negative bacteria while sparing the surrounding microbiome to interrupt infection-driven disease. Its pipeline targets bacterial drivers across oral and gastrointestinal diseases, infection-associated cancers, and women's health conditions.
- Who are Flightpath's investors?
- Flightpath's investors include First In Ventures, ID Ventures, Michigan Rise.